© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Years ago, researchers in the pharmaceutical sector set out to tackle stubborn fungal infections that resisted older treatments. The birth of bifonazole came from this constant drive to push beyond limitations, and it started showing up in labs around the late 1970s. The development process involved rigorous screening of azole derivatives, leading to a molecule with a unique edge: it hit a broader range of fungi than earlier azoles. This breakthrough didn’t catch everyone’s attention right away, but doctors and patients dealing with lingering skin conditions took notice once bifonazole creams got approved. Once regulatory agencies in Europe saw the supporting clinical evidence, the floodgates opened, and new formulations kept arriving for local and international markets.
Bifonazole usually comes as a topical antifungal cream, sometimes as a solution or powder for those needing something different. Unlike products that simply suppress surface symptoms, this compound digs deeper, working through the various layers of skin where fungal cells hide. The antifungal action spans dermatophytes, yeasts, and molds, which brings relief for folks struggling with athlete’s foot, ringworm, and candidiasis. By blocking ergosterol synthesis, bifonazole destroys fungal structure, so it doesn’t just patch up the problem. The single daily dosing stands out for people looking for medicine routines that don’t disrupt daily life.
A bifonazole molecule shows up as a near-white crystalline powder, with barely any smell and no notable taste. It melts at around 146 to 149°C, and dissolves slowly in water, so most manufacturers rely on alcohol or other solvents to boost absorption. Bifonazole carries the chemical formula C22H18N2, and the molecular weight falls just above 310 g/mol. The compound holds up well when stored away from light, and exposure to moisture or heat can nudge it toward degradation, so packaging always has to put stability first. In my time visiting pharmaceutical plants, the handling protocol for bifonazole demands airtight storage and well-marked containers, since any slip in humidity control will hit product performance on pharmacy shelves.
Pharmaceutical-grade bifonazole gets strict evaluation before reaching pharmacies. Powder purity sits above 99%, with close monitoring for impurities that can throw off results in the final cream or powder. Labeling on the finished package needs to state bifonazole’s concentration — usually 1% for topical creams — plus precise application instructions. Warnings about avoiding mucous membranes, eyes, and deep open wounds come out clear in bold text. Patient leaflets stick to the basics: wash and dry the area, apply a thin layer, let it absorb before dressing. Every country’s drug authority lays out a framework for what must appear on boxes and tubes, but most details — expiry date, batch number, manufacturer — show a commitment to safety, not just ticking regulatory boxes.
Making bifonazole starts with controlled condensation reactions involving imidazole rings and aromatic substituted benzenes, followed by purification through steps like crystallization and solvent washes. Scaling up from lab bench to industrial reactors throws up challenges such as handling volatile reagents and keeping post-reaction impurities under control. Most modern synthesis routes refine product yield and bring down byproducts, thanks to a better understanding of reaction kinetics. Keeping airborne particles to a minimum in the production line, along with employing air curtains and containment, helps reduce contamination. Production teams document each batch’s processing times, reagent lots, and exact handling temperatures to assure downstream quality in the finished product.
Chemists working on bifonazole study possible tweaks to the structure to nudge activity or solubility in a particular direction. Changing one of the benzene ring’s substituents or introducing a new group to the imidazole backbone can influence its spectrum or tissue penetration. These modifications don’t just pop up in academic journals — they tie directly to the next wave of antifungals that might tackle resistant strains or classic side effects like local irritation. A careful eye on bifonazole’s main metabolites, especially after topical use in animals and people, gives clues about safety and possible improvements. Pharmaceutical scientists weigh the tradeoff between enhancing fungicidal capability and not crossing over into human toxicity.
Bifonazole got its official name through international chemical nomenclature rules, but pharmacy windows and online shops list it under plenty of aliases: Mycospor, Canespor, and other house brands. Some older papers might call it by experimental codes, like Bay R 4852, left over from the original development phase. I’ve noticed doctors often mention the brand, while chemists and pharmacists prefer the INN (International Nonproprietary Name), keeping things precise. No matter the label, the active molecule stays the same.
Tubes and jars of bifonazole in any clinic reflect a strong foundation of safety work. Safety forms tracked in manufacturing plants show strict limits for airborne dust, proper respirators for line workers, and closed transfer systems for bulk powders. On the patient end, the main warnings link to rare local reactions: mild stinging, a little redness. At least—based on published research and my pharmacy rounds—allergy flare-ups stay uncommon, especially with short treatment courses. Regulatory agencies like the EMA and FDA update their safety advisories as adverse event reports roll in, but so far, the risk count points to bifonazole as a relatively safe option for cutaneous mycoses compared to older, more irritant-prone alternatives.
This antifungal started out as a cream for irritated athlete’s foot, but over time found its way onto shelves for a broader list of fungal woes: interdigital tinea, pityriasis versicolor, and nailbed infections. Hospitals and outpatient clinics saw value in bifonazole for diabetic foot care, where fungal infections can spiral out of control if left unchecked. For the average family, sports injuries or repeated pool use bump up the risk of tinea, and bifonazole often gets the call due to its short treatment window and user-friendly format. Specialist clinics might use it for patients who can’t tolerate oral antifungals, or in combination with other agents in rare, extensive skin conditions.
R&D teams keep pressing for faster, safer fungicidal action, and bifonazole still attracts attention decades after its launch. Research looks at adding it to new bases: foam sprays, barrier films, or slow-release patches that help people with limited mobility. Clinical pharmacology dives deep, parsing skin absorption rates and comparing patient outcomes against newer azoles. At conferences, case studies roll out showing bifonazole’s effect against unusual fungal strains, especially where resistance is rising. University collaborations sometimes point to repurposing — testing bifonazole in antifungal coatings for medical implants or as part of veterinary antifungal kits, as fungal disease isn’t just a human problem.
Toxicologists who have evaluated bifonazole report that systemic toxicity sits very low after topical use, with blood levels rarely crossing the threshold of concern even after generous applications. Long-term animal studies tracked exposure at doses much higher than humans would see, observing that the main risks cluster around local swelling and, after months of massive exposures, some liver enzyme changes that didn’t carry over to people. Researchers double-check for any carcinogenic or mutagenic risks, but so far nothing significant sticks out. In clinics, doctors field more questions about allergies or irritation than about deeper organ risks. In rare patch test reactions, discontinuation clears up symptoms.
Looking ahead, demand stays strong for antifungals that hold off resistance and cut down on side effects. Bifonazole’s proven track record means it won’t vanish from pharmacy counters anytime soon, but researchers and pharmacists agree that contact time and better skin penetration will drive the next batch of product improvements. Combining bifonazole with agents that repair skin or stop itching holds promise for patient comfort. Public health bodies keep warning about the dangers of severe or chronic fungal infections, especially in diabetes or immunosuppression, so fast and reliable topical options have a big part to play. Digital health apps tracking medication adherence might help boost cure rates in the years to come. Generics will keep bifonazole affordable, giving doctors and families a reliable first line whenever superficial fungal infections show up.
Bifonazole goes beyond a fancy pharmaceutical name. It’s an antifungal tool found in many over-the-counter creams and powders, trusted by dermatologists and ordinary folks. People use it to tackle fungal infections that show up on feet, groins, and even in those annoying spots under the arms and breasts. Athlete’s foot, jock itch, and some yeast-related rashes all shrink away after a steady routine with this cream. That’s the real value here—relief for itching, scaling, and discomfort people would rather forget about.
Fungal infections tend to get brushed off as minor annoyances, but anyone who’s wrestled with a stubborn case can tell you how much it can mess with daily life. Years ago, I spent a summer coaching youth soccer. By July, close to half the kids had peeling, cracked skin between their toes and a rash creeping up from their ankles. Feet stuck in sweaty socks make it easy for athlete’s foot to take hold. Back then, Bifonazole cream at the pharmacy meant parents could deal with mild infections at home, no fuss or embarrassment for their kids.
There’s another side to this: fungal infections actually spread fast, especially in shared showers or gyms. One small patch can turn the locker room into an itchy minefield. Good antifungal care acts as more than treatment; it’s prevention for future outbreaks. That’s what makes these creams essential for active families, gym regulars, and people working long hours in boots. Quick action means fewer days spent scratching and fewer chances of infection spreading to someone else.
Doctors favor Bifonazole for its straightforward action. It blocks a key step in the way fungi make their cell membranes, which weakens and kills the invading organisms. Research available on PubMed and Healthline confirms that this medicine has a broad reach, dealing with different types of fungi, not just one or two. Even yeast-related skin infections, which don’t always respond to cheaper antifungal powders, tend to clear up with regular Bifonazole use.
Small infections sometimes grow into bigger skin problems if ignored. Scratching and cracked skin easily pick up bacteria. Hard-earned confidence, especially for teens or those with recurring infections, takes a hit from blotchy, visible rashes. Returning to clear skin isn’t just about avoiding embarrassment, it’s about feeling comfortable at work, school, or gym. Prompt treatment improves lives in real, visible ways.
Creams like Bifonazole aren’t miracle fixes. Directions on the box really do matter. Rushing it or stopping after symptoms fade only invites the fungus back. Physicians recommend washing and drying the affected area before applying, and finishing out the full course—usually two to four weeks. Side effects stay rare, limited to mild redness in most cases. Allergic reactions can happen but rarely do. If an infection doesn’t budge or spreads, medical help offers the best next step.
Bifonazole shows its strength through practical, everyday use. People who understand their habit and environment—like folks wearing the same sweaty sneakers after a gym workout—take small steps to prevent repeat outbreaks. Washing socks in hot water, wearing flip-flops in communal showers, and letting feet dry out properly all help these creams do their job. If pharmacies and clinics carry trustworthy antifungal options like Bifonazole, communities feel the benefit directly—fewer outbreaks and less awkwardness about seeking care.
Dealing with athlete’s foot, ringworm, or other fungal skin troubles can distract you from everything else going on. Pharmacies offer many treatments, but Bifonazole cream stands out for its broad action against itchy, scaly skin issues. Doctors recommend it quite a bit. If you’re fighting off stubborn ringworm patches or the flaky skin between your toes, rushing application leads to poor results. Guided by experience, I see how following good application habits boosts the chance of getting past these persistent skin foes.
Real relief starts before you even crack open the tube. Filthy feet or sweaty underarms feed fungus. Wash with mild soap and make sure the skin is dry. A towel dab works fine, but air drying can help cover those hard-to-reach cracks. Skipping cleaning drags out healing or invites re-infection.
The only way the medicine gets where it’s needed comes through a simple act—hands-on, literally. Squeeze a thin strip onto a finger. Too much cream wastes product and can clog pores, making irritation worse. Gently rub a thin layer over the affected patch and nearby skin, even an inch beyond the obvious rash. Fungi don’t stop at clear lines, they can sneak a bit past the visible border.
Massaging in the cream drives the medicine into skin folds and cracks. If the rash appears on tough feet, don’t just dab and dash—press gently and make sure you're not missing spots between toes or under nails. For sweaty spots like underarms, let the area stay open to the air a few minutes post-application.
Missing doses lets fungus regroup. Most prescriptions read apply once daily, usually in the evening. Sticking with this, even after redness and itching calm down, supports full recovery. Stopping too soon ranks high among reasons fungi return. Two to four weeks often clear up infections, but some patches require longer. If nothing changes after three weeks, I’ve seen most doctors recommend getting checked again—sometimes rashes mask more serious skin problems.
After treating your rash, clean your hands thoroughly. Otherwise, you might spread the infection or get the cream into your eyes. If you are treating someone else, disposable gloves make a big difference in avoiding a second infection.
Ignorance lets fungal infections simmer. Some folks skip cleaning shoes or socks; fungi thrive on damp, dirty fabric. I’ve seen relief come faster when families wash socks in hot water, dry shoes, and change sheets often. Wear sandals in communal showers. Athletes take extra steps with powders to keep feet dry. If skin cracks bleed or new blisters pop up, a trip to a healthcare provider beats trying to tough it out alone.
People getting prompt advice from pharmacists or doctors usually tackle skin fungus faster. Don’t hesitate to ask about side effects, allergy signs, or whether it’s safe to combine Bifonazole cream with other treatments. Trust grows with knowledge and action, not just reading the packaging.
Bifonazole steps into the scene as a trusted ally against fungal skin infections. It’s found its spot in all sorts of creams and sprays you can pick up at the pharmacy. Folks use it to battle athlete’s foot, ringworm, or those flaky, itchy patches that just won’t let go. Dermatologists have counted on this medication for decades, but using anything on your skin can have a downside.
Let’s get practical. Most people who reach for bifonazole deal with mild side effects—if they happen at all. You might see a bit of redness, maybe even some peeling, or feel a slight burn after the cream goes on. I’ve had moments after applying antifungal creams where my skin stung or grew warm. It’s rarely a sign of a serious problem, more like a temporary annoyance that fades after a few days. Medical studies and published reports say the same. Only about 1–3% of users notice these effects, and they tend to stick around for a couple days, not weeks.
Folks with sensitive skin or those prone to allergic reactions see rashes and swelling more often. Some people break out in hives or develop blisters. Anyone with a history of strong skin allergies—like reacting to perfumes or other creams—knows this risk all too well. I’ve heard stories from people I trust who developed irritation the moment the cream hit a patch of eczema or a scraped area. Small children and older adults seem to have thinner, more reactive skin, so they might need a little extra watchfulness.
It’s rare for topical bifonazole to travel into your bloodstream enough to cause headaches or nausea. There’s not much evidence to show this happening often. The body does a pretty good job of keeping most of the medicine near the skin’s surface. That said, anyone who feels sick, dizzy, or has trouble breathing after using a skin cream needs medical advice, especially if there’s a known allergy to antifungal products.
Most problems with bifonazole come from using it too much or on broken skin. Sticking to clean, dry skin makes a huge difference. Washing your hands both before and after helps protect other areas—no one wants an itchy patch to spread. If you’ve ever had a tough case that doesn’t clear, itching might be due to something else, like eczema or psoriasis. Kicking this around with your doctor can clear up confusion and make sure you’re using the right product for the real problem.
Keep an eye on your skin during those first few days, and don’t push through pain or blisters. Some people benefit from doing a quick patch test on a small spot before spreading the cream over larger areas. Healthcare providers give this advice for a reason—allergic reactions rarely pop up if you test first. And remember, always finish the full treatment unless told otherwise, since stopping early gives fungus time to bounce back.
Nobody enjoys rashes or irritation, so open up about anything unusual with your pharmacist or doctor. The medical community has plenty of options and solutions, even for sensitive folks. Bifonazole stays popular because most people get relief without much downside, making it a steady choice for everyday fungal infections.
Anyone who finds out they’re expecting or nursing a baby starts thinking twice about every medicine, skin cream, and food. It isn’t about fear-mongering — it’s about wanting the best for a child growing inside or depending on you. If a fungal infection hits, the grocery store shelf seems endless, but for some, the search quickly boils down to a single question: “Can I use this safely?” Bifonazole, an antifungal cream, often lands right in the middle of that question mark.
I worked in local pharmacy outreach for pregnant teens for four years, and sometimes my job was fielding those frantic Sunday night calls. The truth: No one wants uncertainty. For bifonazole, doctors often pause and dig through the studies. So far, human research on bifonazole in pregnancy seems pretty thin. The data mostly comes from animal tests, and those don’t quite capture what could happen in a real pregnancy. The biggest clinical advice out there says: skip unless essential, and don’t use on big skin areas.
At a parent support group last year, a dermatologist talked frankly: If a pregnant patient shows up with athlete’s foot so severe it impacts her ability to walk, he thinks through other remedies first. If nothing else works, a short-term, sparing approach with bifonazole might be considered — but only if the benefits truly outweigh any possible risks. He always checks with the OB/GYN and involves the mom in the conversation.
Prescription choices sometimes come down to a gut feeling backed up by studies, but for lots of pregnancy medications, those studies just haven’t happened. With bifonazole, no massive, high-quality trials in pregnant women exist. European drug regulators label it as a last resort for pregnancy, not a go-to. The U.S. FDA skips assigning it a “category,” because the system changed, but they recognize the lack of hard evidence too. Health Canada echoes the same opinion.
With breastfeeding, the science gets murkier. If bifonazole applies onto a small, non-breast area, health agencies call it “possibly safe.” But put it near the nipples, or anywhere a baby might suck or touch — that’s a no-go zone. Babies have thinner skin and they absorb drugs like little sponges. Fungal infections around or under the breast need a chat with a pediatrician and a doctor before reaching for any creams.
Moms-to-be and new mothers aren’t simply looking to treat a rash — they’re balancing relief with worry. Over-the-counter labels don’t replace honest advice. As a health advocate, I saw success with simple strategies: calling pharmacists who double-check with primary doctors, keeping a list of known-safe topical antifungals (like clotrimazole), and never, ever slathering creams on broken skin or large areas without guidance.
One solution: doctors, pharmacists, and patients all share information rather than assume someone else will handle the safety research. More transparency in labeling would help, bringing every risk and alternative to the forefront. If someone’s worried, asking for help instead of guessing goes much further than any catchy product slogan.
Pregnancy and breastfeeding already come with enough unknowns. Skipping unnecessary risks makes sense, especially when medicine cabinets brim with options. Honest answers calm nerves better than vague promises. Real health grows from knowing medicine’s limits and pushing for better answers, both from doctors and from the science behind every common cream or pill.
Fungal skin infections have a stubborn reputation. Anyone who’s had athlete’s foot or a rash between their toes knows why folks reach for fast, reliable solutions. Bifonazole, an antifungal cream, pops up on pharmacy shelves promising to clear things up. It’s fair to wonder how quickly those red patches or peeling skin will settle down once you start using it.
Bifonazole attacks fungi by blocking how they produce ergosterol. Without ergosterol, the fungal cell wall falls apart. That’s good news for irritated feet since the fungus can’t stick around once the wall’s cracked. When you rub bifonazole into the skin, the active ingredient sinks in and gets to work breaking down the source of the itch. Most creams instruct users to apply once per day, which beats the twice-a-day hassle of some other antifungals.
I remember treating an itchy rash caused by a workout at the local community pool. The over-the-counter cream worked, but it took a bit of patience. I wanted instant results, but things just don’t clear up overnight. Actual improvement creeps up slowly as the topical drug clears away the underlying infection.
On average, most people start noticing improvements within a week. The redness may fade, the itch lets up, and blisters stop spreading. Full recovery takes longer. Clinical trials and product leaflets point to two to four weeks for most common infections. Nail fungi take even longer—sometimes three months or more if a doctor prescribes bifonazole-based treatments for nails. Sometimes, it feels like a drag to stick with a daily cream routine, especially when the rash seems mostly gone after a few days. Stopping too soon leads to relapses, which makes treatment seem like a never-ending cycle.
Skin sheds naturally over a month, so the visible damage lingers even after most of the fungus disappears. A study from Germany on athlete’s foot found that 80% of people reported clear or nearly clear skin after four weeks of daily application. Those numbers track with what you’ll hear from pharmacists who have watched patients waver, stop too early, or forget to wash the area before applying cream.
Not every infection responds the same. Factors like underlying health conditions or severe cracks in the skin slow healing. People with diabetes or weak immune systems often fight skin problems for longer. Some forms of athlete's foot, such as moccasin-type, don’t always clear as quickly or completely as the angry, itchy type between the toes.
Poor application habits also trip people up—if someone forgets a day here and there, or covers the area too soon, recovery stalls out. Moist feet, poor hygiene, and tight shoes invite new infections even during treatment.
Consistency beats impatience. I found a post-shower habit worked best, since clean skin helps the medicine soak in. Drying off thoroughly before application and sticking with treatment for at least the recommended full period gave my skin the best chance. Medical guidelines stress not quitting too early—finish the course, and the odds of a repeat problem go down. If things don’t clear after a month, seeing a doctor makes sense to rule out other skin issues or resistant organisms.
Bifonazole clears most everyday fungal rashes, but not instantly. Building a habit, cleaning the skin, and following directions will lead to good results for most people and can keep stubborn skin outbreaks at bay.
| Names | |
| Preferred IUPAC name | 1-[(1H-Imidazol-1-yl)(phenyl)methyl]-1-phenylethanol |
| Other names |
Bifonazol Bay 11824 Monocozol Mycospor Canespor |
| Pronunciation | /baɪˈfɒn.ə.zɒl/ |
| Identifiers | |
| CAS Number | 60628-96-8 |
| Beilstein Reference | 3564297 |
| ChEBI | CHEBI:3095 |
| ChEMBL | CHEMBL1431 |
| ChemSpider | 54677 |
| DrugBank | DB04787 |
| ECHA InfoCard | 100.054.103 |
| EC Number | EC 245-630-1 |
| Gmelin Reference | 68061 |
| KEGG | D07657 |
| MeSH | D001650 |
| PubChem CID | 2157 |
| RTECS number | DG8460000 |
| UNII | HG2S6H5958 |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C22H18N2 |
| Molar mass | 311.8 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.14 g/cm3 |
| Solubility in water | Insoluble |
| log P | 2.99 |
| Acidity (pKa) | 6.56 |
| Basicity (pKb) | 6.30 |
| Magnetic susceptibility (χ) | -74.0e-6 cm^3/mol |
| Refractive index (nD) | 1.558 |
| Dipole moment | 3.76 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 572.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -7286 kJ/mol |
| Pharmacology | |
| ATC code | D01AC10 |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315, H319, H335 |
| Precautionary statements | P101, P102, P264, P273, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | Health: 1, Flammability: 1, Instability: 0, Special: - |
| Flash point | Flash point: 228.4 °C |
| Autoignition temperature | 230°C |
| Lethal dose or concentration | LD50 (oral, rat): > 2000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Rat oral >1000 mg/kg |
| NIOSH | RX8460000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 1–2 weeks |
| Related compounds | |
| Related compounds |
Econazole Isoconazole Clotrimazole Miconazole Ketoconazole |
